Navigation Links
Doctors Warn of Deficiencies in Antenatal HIV Testing

Last month, the BMJ reported that rates of mother to child transmission of HIV are dramatically reduced by antiretroviral use, caesarean section, and avoidance of breastfeeding. However, none of these interventions can take place without awareness of the mothers HIV status, argue two senior doctors from Warwickshire Hospital in Coventry.

In the United Kingdom, all antenatal clinics routinely offer HIV testing. Most mothers accept screening, but two recent cases, they say, highlight the deficiencies in the existing system.

In 2006, two infants were diagnosed with HIV within a few weeks of one another. Both mothers had had antenatal screening, and both tested HIV negative.

The authors warn that women who seroconvert during pregnancy (develop antibodies in their blood as a result of infection) are at a greater risk of transmitting HIV to their babies as the mothers viral load is at its highest at this stage.

Alternatively, they explain, both patients may have been tested during the serological window period (the stage immediately after infection when the virus cannot be detected).

They point out that the information leaflet on HIV testing produced by the Department of Health does not include an explanation about the HIV window period, and retesting is not routinely offered to those at higher risk.

Following these two cases, local antenatal services have altered their HIV testing policies to offer repeat testing of high risk individuals at 32 weeks of pregnancy and midwives are being advised to consider ongoing risks in all women, they say.

Contact tracing as is currently offered to HIV positive women should be offered to high risk HIV negative women as well.

They also suggest that high risk women who initially refuse testing in pregnancy should be offered counselling by trained health advisers, with mechanisms in pace to offer testing again later in their pr egnancy.

We see this as a safety net for those let down by the current antenatal system, they conclude.


'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to compare student test score performance for the 2015-16 school year across Wisconsin’s ... voucher programs. Though it highlights important patterns in student test score performance, the ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to ... of acute or chronic problems, I focus on preventative care with all my patients to ... have any questions, always feel free to contact my office and my trained staff will ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology: